State-dependent mibefradil block of Na+ channels

Molecular Pharmacology

Volumn 66, Issue 6, 2004, Pages 1652-1661

  McNulty, Megan M ^a   Hanck, Dorothy A ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC 6094 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIBEFRADIL; SODIUM CHANNEL; SODIUM ION;

ARTICLE; BRAIN; CELL MEMBRANE DEPOLARIZATION; CHANNEL GATING; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; PERIPHERAL NERVE; PRIORITY JOURNAL; SKELETAL MUSCLE;

EID: 9444260424     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.66.6.1652     Document Type: Article

References (44)

1. + channel alpha subunit with novel gating properties. Neuron 1:449-461.
2. Balser JR (2001) The cardiac sodium channel: gating function and molecular pharmacology. J Mol Cell Cardiol 33:599-613.
3. Bean BP, Cohen CJ, and Tsien RW (1983) Lidocaine block of cardiac sodium channels. J Gen Physiol 81:613-642.
4. Benardeau A and Ertel EA (1998) Selective block of myocardial T-type calcium channels by mibefradil, in Low-Voltage-Activated T-type Calcium Channels (Tsien RW, Clozel J-P and Nargeot J eds) pp 386-394, Adis International Limited, Tattenhall, England.
5. Bennett PB, Valenzuela C, Chen LQ, and Kallen RG (1995) On the molecular nature of the lidocaine receptor of cardiac Na+ channels. Modification of block by alterations in the alpha-subunit III-IV interdomain. Circ Res 77:584-592.
6. Chahine M, Besehenes I, Trottier E, Chen LQ, and Kallen RG (1997) Restoration of fast inactivation in an inactivation-defective human heart sodium channel by the cysteine modifying reagent benzyl-MTS: analysis of IFM-ICM mutation. Biochem Biophys Res Commun 233:606-610.
7. Chen Z, Ong BH, Kambouris NG, Marban E, Tomaselli GF, and Baiser JR (2000) Lidocaine induces a slow inactivated state in rat skeletal muscle sodium channels. J Physiol 524 Pt 1:37-49.
8. + channels involved in long QT syndromes, are targets for calcium channel blockers. Mol Pharmacol 54:695-703.
9. Clozel JP, Ertel EA and Ertel SI. Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker. J Hypertens Suppl 15:817-25, 1997.
10. Cummins TR, Howe JR, and Waxman SG (1998) Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J Neurosci 18:9607-9619.
11. Eller P, Berjukov S, Wanner S, Huber I, Hering S, Knaus HG, Toth G, Kimball SD, and Striessnig J (2000) High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br J Pharmacol 130:669-677.
12. Goldin AL (2001) Resurgence of sodium channel research. Annu Rev Physiol 63:871-894.
13. Goldin AL (2003) Mechanisms of sodium channel inactivation. Curr Opin Neurobiol 13:284-290.
14. 2+ current. Am J Physiol 280: C1327-C1339.
15. Hanck DA, Makielski JC, and Sheets MF (2000) Lidocaine alters activation gating of cardiac Na channels. Pflueg Arch Eur J Physiol 439:814-821.
16. + channel inactivation gating. Circ Res 75:1:4-122.
17. Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497-515.
18. Kambouris NG, Hastings LA, Stepanovic S, Marban E, Tomaselli GF, and Balser JR (1998) Mechanistic link between lidoeaine block and inactivation probed by outer pore mutations in the rat μ1 skeletal muscle sodium channel. J Physiol 512:693-705.
19. + channel inactivation gate during inactivation. J Biol Chem 271:30971-30979.
20. Klugbauer N, Zong XG, and Hofmann F (1998) Interaction of mibefradil with T- and L-type calcium channels, in Low-Voltage-Activated T-type Calcium Channels (Tsien RW, Clozel J-P and Nargeot J eds) pp 378-385, Adis International Limited, Tattenhall, England.
21. Leuranguer V, Mangoni ME, Nargeot J, and Richard S (2001) Inhibition of T-type and L-type calcium channels by mibefradil: physiologic and pharmacologie bases of cardiovascular effects. J Cardiovasc Pharmacol 37:649-661.
22. + currents in human fusion-competent myoblasts. Br J Pharmacol 126:245-250.
23. Makielski JC and Falleroni MJ (1991) Temperature dependence of sodium current block by lidocaine in cardiac Purkinje cells. Am J Physiol 260:H681-H689.
24. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, and Hanck DA (2000) Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295:302-308.
25. McDonough SI and Bean BP (1998) Mibefradil inhibition of T-type calcium channels in cerebellar Purkinje neurons. Mol Pharmacol 54:1080-1087.
26. McNulty MM and Hanck DA (2002) State-dependent, isoform independent block of Na channels by mibefradil. Biophys J 82:85a.
27. 2+ channels. J Pharmacol Exp Ther 271:1483-1488.
28. v3.2 calcium channels. Mal Pharmacol 61:682-694.
29. 2+ channels by Ro 40-5967. J Pharmacol Exp Ther 269: 178-183.
30. 2+ channels by Ro 40-5967. Circ Res 75:144-148.
31. - channels in macrovascular endothelial cells. Br J Pharmacol 121: 547-555.
32. Nilius B, Prenen J, Voets T, Eggermont J, and Droogmans G (1998) Activation of volume-regulated chloride currents by reduction of intracellular ionic strength in bovine endothelial cells. J Physiol 508:353-361.
33. Nuss HB, Tomaselli GF, and Marban E (1995) Cardiac sodium channels (hH1) are intrinsically more sensitive to block by lidocaine than are skeletal muscle (μ1) channels. J Gen Physiol 108:1193-1209.
34. v1.5) sodium channels. J Physiol 541:701-716.
35. + channel chimaeras. J Physiol 515:61-73.
36. Perchenet L and Clement-Chomienne O (2000) Characterization of mibefradil block of the human heart delayed rectifier hKv1.5. J Pharmacol Exp Ther 295:771-778.
37. Richmond JE, Featherstone DE, Hartmann HA, and Ruben PC (1998) Slow inactivation in human cardiac sodium channels. Biophys J 74:2945-2952.
38. Sheets MF, Kyle JW, and Hanck DA (2000) The role of the putative inactivation lid in sodium channel gating current immobilization. J Gen Physiol 115:609-620.
39. 2+ current in adult rat sensory neurons: effects of anticonvulsant and anesthetic agents. J Neurophysiol 79:240-252.
40. + channels. J Gen Physiol 110:23-33.
41. Trimmer JS, Coopennan SS, Tomiko SA, Zhou JY, Crean SM, Boyle MB, Kallen RG, Sheng ZH, Barchi RL, Sigworth FJ, et al. (1989) Primary structure and functional expression of a mammalian skeletal muscle sodium channel. Neuron 3:33-49.
42. Vilin YY, Makita N, George AL Jr, and Ruben PC (1999) Structural determinants of slow inactivation in human cardiac and skeletal muscle sodium channels. Biophys J 77:1384-1393.
43. Welker HA, Wiltshire H, and Bullingham R (1998) Clinical pharmacokinetics of mibefradil. Clin Pharmacokinet 35:405-423.
44. +-channel inactivation. Proc Natl Acad Sci USA 89:10910-10914.